Dicerna pharmaceuticals, inc. (DRNA)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13
ASSETS
CURRENT ASSETS:
Cash and cash equivalents

245,479

152,816

47,226

100,321

160,141

54,239

46,399

42,426

43,046

68,789

30,960

38,777

22,873

20,865

32,544

29,187

27,614

56,058

52,943

25,908

22,635

26,067

31,815

77,732

133,792

46,595

Held-to-maturity investments

461,411

196,065

265,484

244,969

211,063

248,387

133,980

39,875

54,770

44,889

44,959

49,953

10,002

25,009

25,002

40,003

53,031

38,551

41,096

69,100

65,035

70,055

61,075

22,526

-

-

Contract receivables

15,000

200,354

3,000

0

0

100,000

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income Taxes Receivable

-

-

-

-

-

-

-

1,583

1,583

1,583

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

8,606

6,934

4,688

4,958

2,160

2,888

3,107

3,728

2,411

3,415

3,915

2,966

2,708

1,952

1,836

1,482

1,167

1,532

1,670

1,733

1,416

1,194

856

1,016

906

2,058

Deferred financing costs

-

-

-

-

-

-

-

-

-

-

-

-

620

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current assets

730,496

556,169

320,398

350,248

373,364

405,514

183,486

87,612

101,810

118,676

79,834

91,696

36,203

47,826

59,382

70,672

81,812

96,141

95,709

96,741

89,086

97,316

93,746

101,274

134,698

48,653

NONCURRENT ASSETS:
Property and equipment, net

7,500

7,076

5,508

4,915

3,971

2,718

1,212

1,293

1,451

1,512

1,704

1,837

2,042

2,234

2,373

2,466

2,536

2,684

2,715

2,584

2,327

2,165

1,892

1,473

911

877

Right-of-use operating assets, net

29,932

30,102

2,224

2,627

3,047

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash equivalents

5,563

3,894

3,544

3,544

3,544

744

744

744

744

744

1,116

1,116

1,116

1,116

1,116

1,116

1,116

1,116

1,116

1,116

1,116

1,380

1,380

1,380

264

264

Held-to-maturity investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13,990

27,033

-

2,501

19,014

20,026

-

-

Other noncurrent assets

5,298

168

4,576

62

63

65

66

66

69

70

72

74

75

76

78

79

80

82

111

188

217

243

-

-

-

-

Total noncurrent assets

48,293

41,240

15,852

11,148

10,625

3,527

2,022

2,103

2,264

2,326

2,892

3,027

3,233

3,426

3,567

3,661

3,732

3,882

17,932

30,921

3,660

6,289

22,286

22,879

1,175

1,141

TOTAL ASSETS

778,789

597,409

336,250

361,396

383,989

409,041

185,508

89,715

104,074

121,002

82,726

94,723

39,436

51,252

62,949

74,333

85,544

100,023

113,641

127,662

92,746

103,605

116,032

124,153

135,873

49,794

LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable

6,497

6,077

3,407

5,636

4,958

5,013

3,595

3,757

2,026

4,920

5,392

4,129

4,085

4,318

3,657

3,223

2,438

2,621

1,370

1,637

1,762

1,237

1,215

1,062

715

1,700

Accrued expenses and other current liabilities

19,087

20,042

18,585

10,515

8,196

9,649

8,101

6,299

6,437

5,726

5,130

5,454

6,262

5,726

6,160

6,090

4,898

6,380

7,991

7,344

4,255

3,845

3,812

2,808

1,947

1,286

Lease liability, current

3,164

3,358

1,710

1,648

1,750

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Estimated Litigation Liability, Current

-

-

0

0

0

10,500

12,797

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue, current

223,556

212,258

95,659

78,073

59,784

68,893

4,635

6,180

6,180

6,180

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

52

28

-

-

-

-

77

79

88

96

105

Current portion of long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,785

4,587

Total current liabilities

252,304

241,735

119,361

95,872

74,688

94,055

29,128

16,236

14,643

16,826

10,522

9,583

10,347

10,044

9,817

9,365

7,364

9,001

9,361

8,981

6,017

5,159

5,106

3,958

6,543

7,678

NONCURRENT LIABILITIES:
Lease liability, noncurrent

20,518

20,141

545

1,035

1,378

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue, noncurrent

327,506

182,730

81,977

104,324

128,295

114,293

-

0

1,545

3,090

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other noncurrent liabilities

555

608

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term payable and accrued interest

-

-

-

-

-

-

-

8,904

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Security deposit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

106

106

-

-

-

Long-term debt-net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

260

Preferred stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

529

Total noncurrent liabilities

348,579

203,479

82,522

105,359

129,673

114,293

-

8,904

-

3,090

-

-

-

-

-

-

-

-

-

-

-

106

106

-

-

789

TOTAL LIABILITIES

600,883

445,214

201,883

201,231

204,361

208,348

29,128

25,140

16,188

19,916

10,522

9,583

10,347

10,044

9,817

9,365

7,364

9,001

9,361

8,981

6,017

5,265

5,212

3,958

6,543

8,467

COMMITMENTS AND CONTINGENCIES (NOTE 8)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

-

-

-

0

-

-

-

0

-

-

-

0

STOCKHOLDERS’ EQUITY:
Preferred stock, $0.0001 par value – 5,000,000 shares authorized; no shares issued or outstanding at March 31, 2020 or December 31, 2019

0

0

0

0

0

0

0

0

0

0

75,983

71,872

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, $0.0001 par value – 150,000,000 shares authorized; 73,779,069 and 71,573,196 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

7

7

7

7

7

7

6

5

5

5

2

2

2

2

2

2

2

2

2

2

3

3

2

2

2

1

Additional paid-in capital

725,707

677,504

620,009

615,014

610,632

605,495

542,572

431,749

419,416

417,037

296,434

298,448

299,044

296,962

294,864

292,524

290,114

287,263

284,886

282,342

234,214

231,741

229,632

228,007

225,595

16,545

Accumulated other comprehensive loss

-

-

-3

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accumulated deficit

-547,808

-525,316

-485,646

-454,856

-431,011

-404,809

-386,198

-367,179

-331,535

-315,956

-300,215

-285,182

-269,957

-255,756

-241,734

-227,558

-211,936

-196,243

-180,608

-163,663

-147,488

-133,404

-118,814

-107,814

-96,267

-85,465

Total stockholders’ equity

177,906

152,195

134,367

160,165

179,628

200,693

156,380

64,575

87,886

101,086

-3,779

13,268

29,089

41,208

53,132

64,968

78,180

91,022

104,280

118,681

86,729

98,340

110,820

120,195

129,330

-68,919

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

778,789

597,409

336,250

361,396

383,989

409,041

185,508

89,715

104,074

121,002

82,726

94,723

39,436

51,252

62,949

74,333

85,544

100,023

113,641

127,662

92,746

103,605

116,032

124,153

135,873

49,794